IFCI analyst review 2026: CMP Rs 61.76, MCap Rs 16,000 Cr, PE NAx. PSU NBFC – Development Finance outlook and technical levels. May 2026.

Marksans Pharma analyst review 2026: CMP Rs 213.40, MCap Rs 8,500 Cr, PE 25x. Pharmaceuticals – Generic Formulations outlook and technical levels. May 2026.

Lenskart Solutions analyst review 2026: CMP Rs 463.50, MCap Rs 15,000 Cr, PE NAx. Retail – Eyewear outlook and technical levels. May 2026.

Apar Industries analyst review 2026: CMP Rs 12,204.00, MCap Rs 20,000 Cr, PE 35x. Cables and Conductors outlook and technical levels. May 2026.

IPCA Laboratories analyst review 2026: CMP Rs 1,639.80, MCap Rs 37,500 Cr, PE 25x. Pharmaceuticals – APIs and Branded Generics outlook and technical levels. May

Azad Engineering analyst review 2026: CMP Rs 1,956.00, MCap Rs 6,000 Cr, PE 60x. Defence and Aerospace Precision Engineering outlook and technical levels. May 2

Exide Industries analyst review 2026: CMP Rs 335.35, MCap Rs 28,500 Cr, PE 35x. Batteries – Lead Acid and Lithium Ion outlook and technical levels. May 2026.

Zaggle Prepaid Ocean Services analyst review 2026: CMP Rs 206.00, MCap Rs 3,500 Cr, PE 50x. Fintech – Prepaid Cards and Spend Management outlook and technical l

Triveni Turbine analyst review 2026: CMP Rs 598.00, MCap Rs 17,000 Cr, PE 55x. Industrial Turbines outlook and technical levels. May 2026.

Mankind Pharma analyst review 2026: CMP Rs 2,493.80, MCap Rs 1,02,000 Cr, PE 32x. Pharmaceuticals – Branded Generics outlook and technical levels. May 2026.